Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2010
06/09/2010CN101721365A Levulose liposome injection and novel application thereof
06/09/2010CN101721364A Aqueous dispersion of camptothecin analogue-phospholipid complex and method for preparing same
06/09/2010CN101721363A Cefixime oral administration mixed suspension and preparation method thereof
06/09/2010CN101721361A Pervone vincamine injection and preparation process thereof
06/09/2010CN101721360A Urapidil fructose injection and preparation method thereof
06/09/2010CN101721359A Potassium dehydroandrogrpholide succinate injection and preparation method thereof
06/09/2010CN101721357A Method for filtering meglumine adenosine cycle phosphate high-capacity injection
06/09/2010CN101721356A Surfactant-free ginkgolide B injection
06/09/2010CN101721355A Quality control method of Levofloxacin nasal drops
06/09/2010CN101721352A Glass slow-release conduit of fat-soluble medicine
06/09/2010CN101721351A Solid dispersion of bystolic or pharmaceutical salt of bystolic, preparation method thereof and use thereof
06/09/2010CN101721350A Folate-mediated targeted polymeric micelle
06/09/2010CN101721349A Injectable in-situ crosslinking aquogel and preparation method and application thereof
06/09/2010CN101721322A Self tanning compositions containing dihydroxyacetone, a retinoid and ascorbic acid glucoside as a stabilizer
06/09/2010CN101720928A Combination for preventing and curing degenerative disease of bone and joint
06/09/2010CN101720883A Application of xylooligosaccharide used as calcium absorption enhancer
06/09/2010CN101555215B Preparation technology of doxycycline hydrochloride for injection
06/09/2010CN101444495B Vitamin E microcapsule preparation method
06/09/2010CN101422446B Vitamin K micro-capsule preparation method
06/09/2010CN101390828B Anticancer composition loaded with anti-metabolism medicine and synergist thereof
06/09/2010CN101385703B Cation adhesion type natamycin nano eye drops
06/09/2010CN101342156B Gernebcin inhalation dust cloud agent
06/09/2010CN101336886B Soluble preparation of breviscapine
06/09/2010CN101301477B Isoquercitrin clathrate and preparation thereof
06/09/2010CN101297973B Highly bioadhesive and thermosensitive hydrogel, and preparation method and application thereof
06/09/2010CN101297808B Compound ofloxacin injection for fowl and preparation method thereof
06/09/2010CN101297795B Compound florfenicol powder for animals and preparation thereof
06/09/2010CN101297794B Compound kanamycin sulphate injection for dogs and preparation thereof
06/09/2010CN101279980B Separation and purification method of cefminox sodium and preparation of cefminox sodium freeze-dried powder injection
06/09/2010CN101278924B Meclofenoxate hydrochloride microcapsule and method for preparing injection thereof
06/09/2010CN101278921B Triopisetron Hydrochloride microcapsule and method for preparing injection
06/09/2010CN101278897B Process for preparing brevifolin solid lipid nano particle
06/09/2010CN101273968B Maduramicin ammonium solid dispersion and method for preparing the same
06/09/2010CN101270052B Eugenol aspirin ester pharmaceutical compound, preparation and preparing method
06/09/2010CN101269219B Method for preparing oligose absorbent charcoal carrier sustained-release agent
06/09/2010CN101265265B Method for producing high-purity azlocillin sodium and powder injection thereof
06/09/2010CN101259206B Medicine for curing oral ulcer
06/09/2010CN101259135B Antidiarrheal pharmaceutical composition for animals and preparation method thereof
06/09/2010CN101259116B Externally-applied drug delivery preparations containing bullatacin part medicine exquisite articles
06/09/2010CN101259098B Long-acting low molecule heparin intraocular sustained-release system
06/09/2010CN101239163B Medicaments for resisting microwave radiation
06/09/2010CN101234173B Medicament for treating perianal abscess and preparation thereof
06/09/2010CN101229122B Zanamivir nasal in situ jellies with phase variation property and preparing method thereof
06/09/2010CN101224231B Method of extracting immunologic adjuvant component from cochinchina momordica seed
06/09/2010CN101219220B Remifentanil polymer sustained-release analgesic and its preparing process
06/09/2010CN101215313B Marsdenia tenacissima carbon-21 steroid saponin mixture with antineoplastic effect
06/09/2010CN101194923B Novel medicament for treating systematic lupus erythematosus
06/09/2010CN101185748B Traditional Chinese medicine preparation for eliminating naevus and stains
06/09/2010CN101181579B Chrysanthemum row containing natural aromatic plant
06/09/2010CN101181576B Jasmine flower strip containing natural aromatic plant
06/09/2010CN101168571B Method for exactly extracting antiviral field pennycress polysaccharide from field pennycress
06/09/2010CN101167763B Monascus and total ginkgolide composition for preventing and treating cardiovascular and cerebrovascular diseases
06/09/2010CN101152491B Alopecia treating medicine, preparing method and uses of the same
06/09/2010CN101134035B Application of sophocarpine in the preparing of medicament for treating inflammation caused by influenza B virus
06/09/2010CN101130067B Preparation for replenishing collagen and method of preparing the same
06/09/2010CN101119989B Chroman derivatives and uses thereof in treating CNS disease
06/09/2010CN101069680B Use of 2-hydroxyl-methyl benzenesulfonic acid in preparing medicine
06/09/2010CN101062085B Condyloma acuminata treating medicine
06/09/2010CN101062047B Combination including isoglycyrrhizinate and oxymatrine and the purpose thereof
06/09/2010CN101056877B Imidazoquinoline compounds
06/09/2010CN101032589B Gynaecological inflammation-treating medicine and its preparation
06/09/2010CN101029051B (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the AMPA receptor
06/09/2010CN101028240B Micro-emulsion/submicro-emulsion in-situ gel preparation for eyes and its making method
06/09/2010CN101010076B Immune function-improving agent
06/08/2010US7732655 Controlled release therapeutic wound dressings
06/08/2010US7732641 Formoterol tartrate process and polymorph
06/08/2010US7732637 Acylamide compounds having secretagogue or inducer activity of adiponectin
06/08/2010US7732623 Form V, having improved water solubility over Form 1; formed by dissolving a metal, ammonium or alkylammonium salt of atorvastatin in a solvent, contacting with a calcium salt and isolating
06/08/2010US7732622 Naphthalene derivatives
06/08/2010US7732618 to inhibit the binding of prostaglandin D2, thromboxanes and/or metabolites to the Chemoattractant Receptor-homologous molecule expressed on T-Helper type 2 cells (CRTH2) receptor, and treat disorders responsive to such inhibition
06/08/2010US7732617 Tocopherol derivatives and uses thereof
06/08/2010US7732615 dosage forms of pimavanserin tartrate, serotonin receptor antagonists, used for the treatment of psychological disorders
06/08/2010US7732611 Amine salt of carbostyril derivative
06/08/2010US7732610 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
06/08/2010US7732609 5-(arylsulfonyl)-pyrazolopiperidines
06/08/2010US7732607 Heteroaryl-substituted diazatricycloalkanes and methods of use thereof
06/08/2010US7732599 from neopterin and/or 6-substituted pterins with improved yield and high stereoselectivity; reduction catalysts
06/08/2010US7732596 2-( beta -D-Glucopyranosyl)-4-(2-phenylethyl)benzo[b]thiophene; prevention or treatment of a disease associated with hyperglycemia such as diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications or obesity
06/08/2010US7732591 for treating a neurodegenerative disorder comprising the steps of surgically implanting a catheter; by brain infusion of small interfering RNA ; without impairment of cell endoplasmic reticulum, spontaneous motor activity, or locomotor activity
06/08/2010US7732588 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue
06/08/2010US7732583 efficient synthetic methods for economically mass producing glycolipids having an immunosuppressive action useful for the treatment of autoimmune diseases; 1,3-O-benzylidene-D-arabino-1,2,3,4-octanetetraol
06/08/2010US7732493 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
06/08/2010US7732492 tablet comprising disintegrant such as carmellose, sodium carboxymethyl starch, croscarmellose sodium, crospovidone, partly pregelatinized starch and low-substituted hydroxypropyl cellulose
06/08/2010US7732491 Poly/ADP-Ribose/polymerase inhibitors (PARP); administering 4-iodo-3-nitrobenzamide, gemcitabine, and carboplatin; gene therapy
06/08/2010US7732490 Treating non-Hodgkin's lymphoma with suberoylanilide hydroxamic acid (SAHA, vorinostat)
06/08/2010US7732489 Topical emulsion-gel composition comprising diclofenac sodium
06/08/2010US7732488 Marine oil derived ethyl ester of eicosapentaenoic acid and docosahexaenoic acid, with specified reduced levels of brominated flame retardants; not a health supplement; treat hypertriglyceridaemia
06/08/2010US7732487 Administering calcium channel modulators such as 13,14-dihydro 15-keto-16,16-difluoroprostaglandin E1, for prophylaxis of brain, cardiovascular, gastrointerstinal, respiratory system, vision or liver disorders
06/08/2010US7732486 Anhydrous silver dihydrogen citrate compositions
06/08/2010US7732485 with phenylgoldtriphenylphospine; for cancers that are resistant to platinum based chemotherapeutic agents
06/08/2010US7732484 Use of selective adenosine A1 receptor allosteric enhancers to manipulate angiogenesis
06/08/2010US7732483 DNA-PK inhibitors
06/08/2010US7732482 mycelium extracts such as 3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]furan-2,5-dione, that inhibits beta-transforming growth factor mediated inflammation and fibrosis
06/08/2010US7732481 Prolinylarylacetamides
06/08/2010US7732480 Bicyclic compounds as modulators of androgen receptor function and method
06/08/2010US7732479 Type II diabetes mellitus, Alzheimer's dementia or diseases, systemic and localized amyloidosis; indole-3-carbinol (3-hydroxymethyl indole), 3-hydroxyindole, and 4-hydroxyindole
06/08/2010US7732478 by decreasing level of interleukin-1 beta in gingival crevicular fluid; for decreasing level of circulating TNF; anti-inflammatory agents; non-insulin dependent diabetes, periodontitis
06/08/2010US7732477 2-heteroarylcarboxylic acid amides
06/08/2010US7732476 contacting target cell, which expresses mutant type or wild type autophosphorylated (p) FLT-3 tyrosine kinase, with N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2(E)-propenamide, and concomitantly contacting cell with 4-benzoyl staurosporine; flow cytometry
06/08/2010US7732475 Substituted pyrazoles, indazoles, 1,2,3-triazoles, or benzotriazoles; anticarcinogenic agents, antiinflammatory agents, antiarthritic agents, transplant rejection; controlled release formulations; aralkylation and amidation of the indazole compound
1 ... 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 2250 2251 2252 2253 2254 2255 ... 7860